Cardiac Biotech Solutions, Inc. (CBSC)
0.0356
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Cardiac Biotech Solutions Research and Development Expense (Annual) : 0.0275M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0275M |
| March 31, 2025 | 0.1732M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.4197M |
| March 31, 2023 | 0.485M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vyome Holdings, Inc. | 0.5883M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |